Health ❯Pharmaceuticals

Weight Loss

GLP-1 Drugs GLP-1 Agonists Semaglutide GLP-1 Medications Clinical Trials Obesity Drugs Drug Development Novo Nordisk Obesity Treatment Wegovy Injectable Drugs Compounded Drugs GLP Inhibitors Addiction Treatment Diabetes Drug Safety Medications Incretin Drugs GLP-1 Treatments Drug Pricing Telehealth Eli Lilly Diabetes Treatments Prescription Medications Weight Loss Pills Counterfeit Medications Prescription Drugs Medication GLP-1 Analog Drugs Childhood Obesity Injectable Medications Obesity Treatments FDA Approvals GLP-1 Inhibitors

E-Prescriptions Curb but Don’t Halt Weight-Loss Drug Prescription Fraud in Northern Germany

Stolen and falsified paper prescriptions continue to surface despite the e-prescription rollout, exposing pharmacies to financial losses under strict confidentiality rules.

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

Germany Faces Surge in Forged Prescriptions for Weight Loss Injections

Ozempic injections fuel £24 billion gourmand perfume boom

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Counterfeit Ozempic Pens and Prescription Forgeries Raise Alarm in Germany

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

Terry Smith Sells Diageo Stake Over Concerns About Weight-Loss Drugs' Impact

Weight Loss Drugs Reshape Food Industry and Consumer Habits

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns

Elon Musk Promotes Weight-Loss Drug Mounjaro in Viral 'Ozempic Santa' Post

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism